Guggenheim restated a “buy” rating on shares of Tempus AI in a research note on Tuesday, February 25th. TD Cowen reiterated a “buy” rating and issued a $74.00 target price (up previously ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $63.78, ...

David R. Epstein, a director at Tempus AI , Inc. (NASDAQ:TEM), recently sold 370 shares of the company's Class A Common Stock.... Investing.com -- TD Cowen reinstated coverage on Tempus AI with a ...

The latest price target for Tempus AI (NASDAQ:TEM) was reported by Needham on May 7, 2025. The analyst firm set a price target for $70.00 expecting TEM to rise to within 12 months (a possible 10. ...

And I suspect AI and technology will produce that. We – I hope it's Tempus, but some company like Tempus will one day understand whether or not a patient is going to respond to an eGFR inhibitor ...

Pathos AI has launched a $400 million funding round and already raised nearly $283 million. The Chicago-based startup formed in 2020 by Tempus AI executives Ryan Fukushima and Eric Lefkofsky is ...

As John Blackledge, senior analyst at TD Cowen, said in a note on Thursday, the AI opportunities Zuckerberg outlined are about "ultimately taking on Google search, iPhone and ChatGPT all at once." ...

TD Cowen Says The chip maker should be boosted by its strong technology, while the firm's long-term outlook is positive, according to the investment bank. NVIDIA (NVDA) Still a Strong AI Bet Amid ...

Elizabeth Krutoholow; VP, Investor Relations; Tempus AI Inc. Jim Rogers; Chief Financial Officer; Tempus AI Inc. Eric Lefkofsky; Chief Executive Officer, Director; T ...